Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Pioglitazone on Reverse Cholesterol Transport and HDL Function in Type 2 Diabetes
NCT01156597Phase 3Completed
- Sponsor
- University of Miami
- Start
- Apr 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by University of Miami. Started Apr 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01156597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156597.